Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease
Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease
Provide patients with serious AdV infection or disease access to treatment with BCV.
Inclusion Criteria:

 -  Confirmed serious AdV infection based on clinical symptoms and laboratory testing
 showing AdV in the blood or other bodily fluids

 -  Able to swallow medication, either tablet or liquid

 Exclusion Criteria:

 -  Previous dosing with Brincidofovir

 -  If female, not pregnant or trying to become pregnant